Survival of aneuploid, micronucleated and/or polyploid cells: Crosstalk between ploidy control and apoptosis

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 651, Issue 1-2, 2008, Pages 30-39

  Decordier, Ilse ^a   Cundari, Enrico ^b   Kirsch Volders, Micheline ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b CNR   (Italy)

Author keywords

Aneuploidy; Apoptosis; Nocodazole; Polyploidy

Indexed keywords

CARBENDAZIM; CASPASE 3; CASPASE 8; CASPASE 9; NOCODAZOLE; PROTEIN P53;

ANEUPLOIDY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL SURVIVAL; CHEMICAL MUTAGENESIS; CHROMOSOME LOSS; CONCENTRATION RESPONSE; CYTOKINESIS; DEPOLYMERIZATION; GENOTOXICITY; HUMAN; IN VITRO STUDY; METAPHASE; MICRONUCLEUS; NONDISJUNCTION; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPINDLE POLE BODY;

ANEUPLOIDY; ANIMALS; APOPTOSIS; CELL SURVIVAL; HUMANS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MODELS, BIOLOGICAL; NOCODAZOLE; PLOIDIES; POLYPLOIDY;

EID: 43049090065     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.10.016     Document Type: Article

References (45)

1. Duesberg P., and Rasnick D. Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil. Cytoskeleton 47 (2000) 81-107
2. Saeter G., Lee C.Z., Schwarze P.E., Ous S., Chen D.S., Sung J.L., and Seglen P.O. Changes in ploidy distributions in human liver carcinogenesis. J. Natl. Cancer Inst. 80 (1988) 1480-1485
3. 6-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas/CD95/Apo-1. Oncogene 23 (2004) 359-367
4. Wahl A.F., Donaldson K.L., Fairchild C., Lee F.Y.F., Foster S.A., Demers G.W., and Galloway D.A. Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nat. Med. 2 (1996) 72-79
5. Casenghi M., Mangiacasale R., Tuynder M., Caillet-Fauquet P., Elhajouji A., Lavia P., Mousset S., Kirsch-Volders M., and Cundari E. p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells. Exp. Cell Res. 250 (1999) 339-350
6. Rigante D., La Torraca I., Avallone L., Pugliese A.L., Gaspari S., and Stabile A. The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever. Eur. Rev. Med. Pharmacol. Sci. 10 (2006) 173-178
7. Sackett D.L., and Varna J.K. Molecular mechanism of colchicine action: induced local unfolding of beta-tubulin. Biochemistry 32 (1993) 13560-13565
8. Verdoodt B., Decordier I., Geleyns K., Cunha M., Cundari E., and Kirsch-Volders M. Induction of polyploidy and apoptosis after exposure to high concentrations of the spindle poison nocodazole. Mutagenesis 14 (1999) 513-520
9. Cross D.M., Sanchez C.A., Morgan C.A., Schimke M.K., Ramel S., Idzerda R.L., Raskind W.H., and Reid B.J. A p53-dependent mouse spindle checkpoint. Science 267 (1995) 1353-1356
10. Minn A.J., Boise L.H., and Thompson C.B. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10 (1996) 2621-2631
11. Di Leonardo A., Khan S.H., Linke S.P., Greco V., Seidita G., and Wahl G.M. DNA rereplication in the presence of mitotic inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57 (1997) 1013-1019
12. Lanni J.S., and Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18 (1998) 1055-1064
13. Margolis R.L., Lohez O.D., and Andreassen P.R. G1 tetraploidy and the suppression of tumorigenesis. J. Cell. Biochem. 88 (2003) 673-683
14. Elhajouji A., Van Hummelen P., and Kirsch-Volders M. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen. 26 (1995) 292-304
15. Elhajouji A., Tibaldi F., and Kirsch-Volders M. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 12 (1997) 133-140
16. Decordier I., Dillen L., Cundari E., and Kirsch-Volders M. Elimination of micronucleated cells by apoptosis after treatment with inhibitors of microtubules. Mutagenesis 17 (2002) 337-344
17. Elhajouji A., Cunha M., and Kirsch-Volders M. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 13 (1998) 193-198
18. Decordier I. Crosstalk Between Ploidy Control and Apoptosis in Human Cells (2006), VUB, Brussels 237 pp
19. Vaux D.L. Apoptosis and toxicology-what relevance?. Toxicology 181-182 (2002) 3-7
20. Schriever-Schwemmer G., Kliesch U., and Adler I.D. Extruded micronuclei induced by colchicine or acrylamide contain mostly lagging chromosomes identified in paintbrush smears by minor and major mouse DNA probes. Mutagenesis 12 (1997) 201-207
21. Shimizu N., Shimura T., and Tanaka T. Selective elimination of acentric double minutes from cancer cells through the extrusion of micronuclei. Mutat. Res. 448 (2000) 81-90
22. Schwartz J.L., and Jordan R. Selective elimination of human lymphoid cells with unstable chromosome aberrations by p53-dependent apoptosis. Carcinogenesis 18 (1997) 201-205
23. Bassi L., Carloni M., Meschini R., Fonti E., and Palitti F. X-irradiated human lymphocytes with unstable aberrations and their preferential elimination by p53/survivin-dependent apoptosis. Int. J. Radiat. Biol. 79 (2003) 943-954
24. Taga M., Shiraishi K., Shimura T., Uematsu N., Oshimura M., and Niwa O. Increased frequencies of gene and chromosome mutations after X-irradiation in mouse embryonal carcinoma cells transfected with the bcl-2 gene. Jpn. J. Cancer Res. 91 (2000) 994-1000
25. Decordier I., Cundari E., and Kirsch-Volders M. Influence of caspase activity on micronuclei detection: a possible role for caspase-3 in micronucleation. Mutagenesis 20 (2005) 173-179
26. Cummings B.S., Kinsey G.R., Bolchoz L.J.C., and Schnellmann R.G. Identification of caspase-independent apoptosis in epithelial and cancer cells. J. Pharmacol. Exp. Ther. 310 (2004) 126-134
27. Sun X., Farlane M., Zhuang J., Wolf B.B., Green D.R., and Cohen G.M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274 (1999) 5053-5060
28. Degterev A., Boyce M., and Yuan J. A decade of caspases. Oncogene 22 (2003) 8543-8567
29. Ferrari D., Stepczynska A., Los M., Wesselborg S., and Schulze-Osthoff K. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. J. Exp. Med. 188 (1998) 979-984
30. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang Reed H.G.J.C., Nicholson D.W., Alnemri E.S., Green D.R., and Martin S.J. Ordening the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144 (1999) 281-292
31. Mollindo F., and Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8 (2003) 413-450
32. Marani M., Tenev T., Hancock D., Downward J., and Lemoine N.R. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol. Cell. Biol. 22 (2002) 3577-3589
33. Gajate C., Barasoain I., Andreu J.M., and Mollinedo F. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2′,3′,4′-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest. Cancer Res. 60 (2000) 2651-2659
34. Schiff P.B., and Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. 77 (1980) 1561-1565
35. Jordan M.A., Thrower D., and Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 51 (1991) 2212-2222
36. Jordan M.A., Thrower D., and Wilson L. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J. Cell Sci. 102 (1992) 401-416
37. Schwerk C., and Schulze-Osthoff K. Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem. Pharmacol. 66 (2003) 1453-1458
38. Gruenbaum Y., Margalit A., Goldma R.D., Shumaker D.K., and Wilson K.L. The nuclear lamina comes of age. Nat. Rev. Mol. Cell. Biol. 6 (2005) 21-31
39. Margalit A., Vlcek S., Gruenbaum Y., and Foisner R. Breaking and making of the nuclear envelope. J. Cell. Biochem. 95 (2005) 454-465
40. Slee E.A., Adrain C., and Martin S.J. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276 (2001) 7320-7326
41. Kottke T.J., Blajeski A.L., Meng X.W., Svingen P.A., Ruchaud S., Mesner Jr. P.W., Boerner S.A., Samejima K., Henriquez N.V., Chilcote T.J., Lord J., Salmon M., Earnshaw W.C., and Kaufmann S.H. Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. J. Biol. Chem. 277 (2002) 804-815
42. Buendia B., Santa-Maria A., and Courvalin J.C. Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis. J. Cell Sci. 112 (1999) 1743-1753
43. Sablina A.A., Ilyinskaya G.V., Rubtsova S.N., Agapova L.S., Chumakov P.M., and Kopnin B.P. Activation of p53-mediated cell cycle checkpoint in response to micronucleus formation. J. Cell Sci. 111 (1998) 977-984
44. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate Jr. M., Kirchner S., Lorge E., Morita T., Norppa H., Surralles J., Vanhauwaert A., and Wakata A. Report from the in vitro micronucleus assay working group. Mutat. Res. 540 (2003) 153-163
45. Kirsch-Volders M., and Fenech M. Inclusion of micronuclei in non-divided mononuclear lymphocytes and necrosis/apoptosis may provide a more comprehensive cytokinesis block micronucleus assay for biomonitoring purposes. Mutagenesis 16 (2001) 51-58